Certolizumab pegol
Certolizumab pegol is a pharmaceutical drug with 63 clinical trials. Currently 3 active trials ongoing. Historical success rate of 90.2%.
Success Metrics
Based on 46 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
10
Mid Stage
40
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.2%
46 of 54 finished
14.8%
8 ended early
3
trials recruiting
63
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission
CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)
Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA)
Clinical Trials (63)
A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission
CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)
Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA)
A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis
A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis
A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice
Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation
Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS
Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis
A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis
Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease
A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo
A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 63